Literature DB >> 17236963

Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma.

Xian-Shu Gao1, Xueying Qiao, Fengpeng Wu, Li Cao, Xianli Meng, Zhiming Dong, Xiaoling Wang, Guodong Gao, Tsung-Teh Wu, Ritsuko Komaki, Joe Y Chang.   

Abstract

PURPOSE: To clarify the radiotherapy clinical target volume (CTV) margin needed for esophageal squamous-cell carcinoma (SCC) and gastroesophageal junction (GEJ) adenocarcinoma. METHODS AND MATERIALS: Surgical specimens of esophageal SCC (n = 34) and GEJ adenocarcinoma (n = 32) were prospectively collected and analyzed for microscopic spread along the esophagus and GEJ both proximally and distally from gross tumor and for lymph node (LN) metastasis.
RESULTS: For SCC, the mean microscopic spread beyond the gross tumor was 10.5 +/- 13.5 mm proximally (<30 mm in 32 of 34 cases) and 10.6 +/- 8.1 mm distally (<30 mm in 33 of 34 cases). For GEJ adenocarcinoma, the spread was 10.3 +/- 7.2 mm proximally (<30 mm in 29 of 29 cases) and 18.3 +/- 16.3 mm distally (<30 mm in 27 of 32 cases). The extent of microscopic spread of cancer was significantly associated with pathologic T stage (p = 0.012). LN metastases were observed in 12 (35%) of 34 patients with middle and lower esophageal SCC and 15 (47%) of 32 patients with GEJ adenocarcinoma.
CONCLUSIONS: The extent of microscopic spread within esophagus (recommended CTV margin) was <30 mm in about 94% of cases of esophageal cancer, except for distal microscopic spread in GEJ adenocarcinoma, in which 50 mm was needed to cover about 94% of cases.

Entities:  

Mesh:

Year:  2007        PMID: 17236963     DOI: 10.1016/j.ijrobp.2006.09.015

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  31 in total

1.  Use of planar kV vs. CBCT in evaluation of setup errors in oesophagus carcinoma radiotherapy.

Authors:  Liliana Martins; Jose Guilherme Couto; Barbara Barbosa
Journal:  Rep Pract Oncol Radiother       Date:  2015-11-14

2.  Radiation therapy in the postoperative management of esophageal cancer.

Authors:  Salma K Jabbour; Charles R Thomas
Journal:  J Gastrointest Oncol       Date:  2010-12

3.  Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.

Authors:  Abraham J Wu; Walter R Bosch; Daniel T Chang; Theodore S Hong; Salma K Jabbour; Lawrence R Kleinberg; Harvey J Mamon; Charles R Thomas; Karyn A Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-02       Impact factor: 7.038

4.  Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning.

Authors:  Karim Sillah; Luke R Williams; Hans-Ulrich Laasch; Azeem Saleem; Gillian Watkins; Susan A Pritchard; Patricia M Price; Catharine M West; Ian M Welch
Journal:  World J Gastrointest Oncol       Date:  2010-04-15

5.  Volumetric modulated arc therapy planning for distal oesophageal malignancies.

Authors:  M A Hawkins; J L Bedford; A P Warrington; D M Tait
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

6.  Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings.

Authors:  Shinichi Shimizu; Masao Hosokawa; Kazuo Itoh; Masahiro Fujita; Hiroaki Takahashi; Hiroki Shirato
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

Review 7.  Imaging strategies in the management of oesophageal cancer: what's the role of MRI?

Authors:  Peter S N van Rossum; Richard van Hillegersberg; Frederiek M Lever; Irene M Lips; Astrid L H M W van Lier; Gert J Meijer; Maarten S van Leeuwen; Marco van Vulpen; Jelle P Ruurda
Journal:  Eur Radiol       Date:  2013-02-13       Impact factor: 5.315

8.  Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers.

Authors:  Gary Y Yang; Susan A McClosky; Nikhil I Khushalani
Journal:  Gastrointest Cancer Res       Date:  2009-03

9.  Motion-compensated FDG PET/CT for oesophageal cancer.

Authors:  Francine E M Voncken; Erik Vegt; Johanna W van Sandick; Jolanda M van Dieren; Cecile Grootscholten; Annemarieke Bartels-Rutten; Steven L Takken; Jan-Jakob Sonke; Jeroen B van de Kamer; Berthe M P Aleman
Journal:  Strahlenther Onkol       Date:  2021-04-07       Impact factor: 3.621

10.  Single-Agent Versus Double-Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial.

Authors:  Zhenhuan Zhao; Yixue Wen; Dongbiao Liao; Jidong Miao; Yan Gui; Hongwei Cai; Yang Chen; Min Wei; Qiang Jia; Honggang Tian; Mingqiang Sun; Yu Zhang; Gang Feng; Xiaobo Du
Journal:  Oncologist       Date:  2020-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.